The School of Integrated Health Sciences promotes, improves, and sustains human health through evidence-based education and advances in research and practice. Faculty are involved in a variety of research projects, and work with students to bring new and innovative ideas to fruition.

Below, explore the school's active grants:

Principal Investigator: Brach Poston
Funding Agency: NIH R15
Amount Awarded: $420,881
Period: 08/01/2017 – 07/31/2021

Principal Investigator: Laura Kruskall
Funding Agency: University of Nevada Cooperative Extension
Amount Awarded: $100,000
Period: 07/1/2019 – 06/30/2021

Principal Investigator: John Mercer
Funding Agency: GOED: State of Nevada
Amount Awarded: $200,000
Period: 07/01/2019 – 12/31/2021

Principal Investigator: Brian Schilling
Funding Agency: Department of Defense
Amount Awarded: $169,632
Period: 01/08/2020 - 01/07/2022

Principal Investigator: Brian Schilling
Funding Agency: GOED: Catalyst Grant Program
Amount Awarded: $49,991
Period: 07/01/2020 – 12/31/2021

Principal Investigator: Laura Kruskall
Funding Agency: Subaward Cleveland Clinc Foundation
Amount Awarded: $26,000
Period: 05/01/2020 – 07/29/2023

Principal Investigator: James Navalta / Graham McGinnis
Funding Agency: Nevada Institute of Personalized Medicine / COBRE
Amount Awarded: $37,375
Period: 07/01/2020 – 06/30/2021

Principal Investigator: Julia Silvernail
Funding Agency: GOED: Catalyst Grant Program
Amount Awarded: $47,779
Period: 07/01/2020 – 12/31/2021

Principal Investigator: Kara Radzak
Funding Agency: GOED: Catalyst Grant Program
Amount Awarded: $26,887
Period: Pending

Principal Investigator: Graham McGinnis
Funding Agency: Regional Alliance of INBRE Networks (Rain) Univ of Nevada Reno Pilot Grant
Amount Awarded: $29,529
Period: Pending

Principal Investigator: Francias Cucinotta
Funding Agency: NIH R01
Amount Awarded: $2,358,072
Period: 08/01/2016 – 07/31/2022

Principal Investigator: Janice Pluth
Funding Agency: NASA
Amount Awarded: $299,188
Period: 07/26/2018 – 07/25/2021

Principal Investigator: Szu-Ping Lee
Funding Agency: NIH K01
Amount Awarded: $654,535
Period: 08/05/2018 – 07/31/2023

Principal Investigator: Szu-Ping Lee
Funding Agency: Encompass Health
Amount Awarded: $5,795
Period: 10/01/2019 – 06/30/2021

Principal Investigator: Szu-Ping Lee
Funding Agency: Florida International University Subaward
Amount Awarded: $3,731
Period: 07/01/2020 – 06/30/2021

Principal Investigator: Hui-Ting Shih / Szu-Ping Lee
Funding Agency: International Society of Biomechanics
Amount Awarded: $2,500
Period: 02/24/2021 – 12/31/2021

Principal Investigator: Thessa Hilgenkamp
Funding Agency: NIH NICHD R00
Amount Awarded: $746,637
Period: 09/20/2019 – 08/31/2022

Principal Investigator: Daniel Young
Funding Agency: Johns Hopkins University Subaward
Amount Awarded: $6,793
Period: 09/30/2020 – 09/29/2021

Principal Investigator: Daniel Young
Funding Agency: Cyrus Tang Foundation
Amount Awarded: $33,500
Period: 02/01/2020 – 11/30/2021

Principal Investigator: Jefferson Kinney
Funding Agency: NIH COBRE Via Cleveland Clinic Foundation Subaward
Amount Awarded: $529,118.80
Period: 09/01/2015 – 08/31/2021

Principal Investigator: Jefferson Kinney
Funding Agency: NIH R01 Via Cleveland Cliniic Foundation Subaward Yr 1
Amount Awarded: $29,900
Period: 08/01/2020 – 07/31/2021

Principal Investigator: Jefferson Kinney
Funding Agency: NIH NIA R01
Amount Awarded: $453,603.36
Period: 09/15/2020 – 05/31/2022

Principal Investigator: Jefferson Kinney
Funding Agency: GOED: State of Nevada
Amount Awarded: $200,000
Period: 07/01/2019 – 12/31/2021

Principal Investigator: Jefferson Kinney
Funding Agency: NIH NIA R01
Amount Awarded: $29,900
Period: 01/01/2021 – 12/31/2021

Principal Investigator: Jefferson Cummings
Funding Agency: NIH NIA R01 Via USC Subaward
Amount Awarded: $454,345
Period: 09/01/2020 – 08/31/2023

Principal Investigator: Jefferson Cummings
Funding Agency: NIH U01 Via Boston Univ. Subaward
Amount Awarded: $17,300
Period: 12/01/2020 – 11/30/2021

Principal Investigator: Jefferson Cummings
Funding Agency: Alzheimer's Drug Discovery Foundation
Amount Awarded: $125,699.08
Period: 01/01/2021 – 12/31/2021

Principal Investigator: Jefferson Cummings
Funding Agency: NIH R01 Via Cleveland Cliniic Foundation Subaward Yr 1
Amount Awarded: $19,158
Period: 08/01/2020 – 07/31/2021

Principal Investigator: Jefferson Cummings
Funding Agency: NIH NIA
Amount Awarded: $597,625
Period: 04/15/2021 – 03/31/2026

Principal Investigator: Samantha John
Funding Agency: NIH R01 Via Cleveland Cliniic Foundation Subaward Yr 1
Amount Awarded: $14,950
Period: 08/01/2020 – 07/31/2021

Employment
UNLV Strong
Wellness
Community
Top Tier 2.0

Campus Notifications
University Statements and Compliance
Web Privacy Statement
Web Accessibility
Website Feedback

University of Nevada, Las Vegas
4505 S. Maryland Pkwy.
Las Vegas, NV 89154
Phone: 702-895-3011
Campus Maps
Parking Information

© 2025 UNLV
Produced by UNLV Web & Digital Strategy

Social Media at UNLV

Find

Quick Links

Breadcrumb

Active Grants

Long Term Transcranial Direct Current Stimulation in Parkinson's Disease

University of Nevada Cooperative Extension-UNLV Food Pantry

Governor's Office of Economic Development - UNLV Sports Research and Innovation Initiative - Sports Equipment for Endurance Performance: Testing, Developing, and Commercialization of Products

The Effects of Fresh Blood Donation on Human Performance in US Special Forces

Governor's Office of Economic Development - UNLV Sports Research and Innovation Initiative Catalyst Grant Program-Proof of Concent - FightPace Mobile Application for Combat Sports Interval Training

Diet Intervention for Woman at Risk of Developing AD

Temporal, Environmental, and Genetic Factors Regulating Exercise and Migraine

Governor's Office of Economic Development - UNLV Sports Research and Innovation Initiative Catalyst Grant Program-Proof of Consent - The Healthy Runner (Run Healthy Mobile Application)

Governor's Office of Economic Development-UNLV Sports Research and Innovation Initiative Catalyst Grant Program- Proof of Consent- Healing the Everyday Athlete-Evaluating the Impact of Incrediwear Use on Musculoskeletal Health in an Occupational Setting

The Effects of Circadian Rhythm Disruption on the Inflammatory Response to Particulate Matter Exposure form Woodsmoke

Biophysical Description of Age and Dose Dependent Changes of Dendritic Morphology that Impact Cognition Following Radiation Cancer Therapy

Microgravity Affects on Mammary 3D Tissue Architecture and Role of Stem Cells and Genetics

Motor Learning in Individuals with and at Risk of Lower Limb Loss: Implications for Amputee Rehabilitation

Mobility and Patient-Perceived Outcomes of Rehabilitation after Lower Extremity Amputation Surgery

Examining Racial/Ethnic Disparities in Functional Outcomes of People with Dysvascular Lower Limb Amputation and the Effect of Socioenvironmental Factors

The Effect of Weight-Shifting Balance Training Intervention on Balance Recovery Response in Individuals with Below the Knee Imputation - Student Award

Central & Peripheral Blood Flow Regulation in Individuals with Down Syndrome

Improving Hospital Efficiency: Predicting Post-Acute Care Facility Placement Using Machine Learning and Patient Mobility Scores form the Electronic Medical Record

An International Collaboration to Understand & Promote Hospitalized Patient Activity and Mobility in Jiangsu Shengze Hospital

COBRE: CNTN Center for Neurodegeneration and Translational Neuroscience

Nevada Exploratory Alzeimer's Disease Research Center (NVeADRC)

Aging and Hyperglycemia Alter Molecular Mechanisms and Hippocampal Oscillations Consistent with Alzheimer's Disease

Governor's Office of Economic Development-UNLV Sports Research and Innovation Initiative-"Characterization of Protein and Genetic Biomarkers to Detect, Predict, Treat, and Best Prevent Traumatic Brain Injury in Multiple Sports

Towards Generating a Multimodal and Multivariate Classification Model from Imaging and Non-Imaging Measures for Accurate Diagnosis and Monitoring of Dementia in Parkinson Disease

Global Alzheimer's Platform Trial-Ready Cohort

Chronic Traumatic Encephalopathy: Detection, Diagnosis, Course, and Risk Factors

5th Annual Goodes Prize for Excellence in Alzheimer's Drug Discovery: Rasagiline Rescur (R2) of Alzheimer's Disease: A Double Blind, Placebo Controlled, Randomized, Parallel Group Clinical Trial in Mild-to Moderate Alzheimer's Disease

Nevada Exploratory Alzeimer's Disease Research Center (NVeADRC)

Alzheimer's Clinical Trial InnOvatioN (ACTION) Initiative

Nevada Exploratory Alzeimer's Disease Research Center (NVeADRC)